Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2003
07/03/2003WO2003053968A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053958A1 Quinazolinedione derivatives
07/03/2003WO2003053957A1 Benzhydryl derivatives
07/03/2003WO2003053956A1 Piperidine-2,6-diones that are heterocyclically substituted in position 3
07/03/2003WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists
07/03/2003WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists
07/03/2003WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives
07/03/2003WO2003053926A1 Novel phenylalanine derivative
07/03/2003WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053473A2 Ph-sensitive polymeric conjugates of an anthracycline drug
07/03/2003WO2003053465A2 Lyophilized preparation containing antibodies to the egf receptor
07/03/2003WO2003053457A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
07/03/2003WO2003053446A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
07/03/2003WO2003053442A1 Tempamine compositions and methods of use
07/03/2003WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
07/03/2003WO2003053440A1 Medicinal composition
07/03/2003WO2003053438A1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer
07/03/2003WO2003053418A1 Ultrapure oral fludara formulation with a fast releasing active substance
07/03/2003WO2003053409A1 Liposome composition for delivery of nucleic acid
07/03/2003WO2003053407A1 Liposomal delivery of vitamin e based compounds
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003WO2003053365A2 Syn3 compositions and methods
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/03/2003WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003WO2003053224A2 Novel compositions and methods for cancer
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053215A2 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
07/03/2003WO2003029488A3 A method for the early detection of cancer
07/03/2003WO2003026643A3 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
07/03/2003WO2003018788A3 Improved nitroreductase enzymes
07/03/2003WO2003016499A3 Combinatorial methods for inducing cancer cell death
07/03/2003WO2003011215A3 Method and system to determine revised dosage
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/03/2003WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures
07/03/2003WO2002079147B1 Inhibitors of prenyl-protein transferase
07/03/2003WO2002076497A3 Method and composition
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2002018389A3 Thienopyrimidine
07/03/2003WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
07/03/2003WO2002012447B1 Isolation and use of solid tumor stem cells
07/03/2003WO2002008281A3 Bstp-cad protein and related reagents and methods of use thereof
07/03/2003WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/03/2003WO2001083750A9 Dendritic cell co-stimulator molecules
07/03/2003WO2000074667A3 Compositions active in telomere damage comprising a taxane and telomerase inhibitor
07/03/2003US20030125800 Drug-delivery endovascular stent and method for treating restenosis
07/03/2003US20030125571 7-hydroxy-3-(4-hydroxyphenyl)-3-methyl-chromene or thiochromene-4-yl)-pentafluoroalkanoic acid or a hydrate useful antiestrogenic or anticarcinogenic agent (breast cancer)
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125523 Novel neuropilin/growth factor complexes and uses thereof
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125388 5-Aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
07/03/2003US20030125387 Antioestrogens, capable of eliciting complete ablation of the trophic effects of oestrogens; cancer therapy
07/03/2003US20030125384 Administering agent that selectively inhibits bacterial DNA replication initiation; for disease or disorder caused by or associated with E. coli or H. pylori infection
07/03/2003US20030125383 For treating or preventing emphysema, cancer and dermatological disorders
07/03/2003US20030125380 Tricyclic rantes receptor ligands
07/03/2003US20030125377 Aromatase inhibitors from Broussonetia papyrifera
07/03/2003US20030125376 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
07/03/2003US20030125375 Eurotinones, and derivatives thereof, processes for preparing them, and their use
07/03/2003US20030125370 Treating or preventing protein kinase related disorders in a organism, such as cancer, diabetes, autoimmune disoders, hyperproliferation diosrders, osteoarthritis, rhematoid arthritis, angiogenesis, immunological disorders
07/03/2003US20030125369 New indenoindolone compounds
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125366 Phorboxazole derivatives for treating cancer
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125359 RAF-MEK-ERK pathway inhibitors to treat cancer
07/03/2003US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation
07/03/2003US20030125346 Amino-substituted pyrimidinyl derivatives and methods of use
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound
07/03/2003US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
07/03/2003US20030125339 Substituted alkylamine derivatives and methods of use
07/03/2003US20030125326 Farnesyl protein transferase inhibitor combinations
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125305 Treating patients who have become resistant to a Brc-Abl tyrosine kinase inhibitor, e.g., imatinib mesylate, with a nucleoside analog of a 2-cytosinyl-1,3-dioxolane; chronic myelogenous leukemia in blastic phase; anticarcinogenic agents
07/03/2003US20030125302 Folic acid-polysaccharide complex, its preparation method and pharmaceutical composition containing the same as active component
07/03/2003US20030125299 Method for treating or preventing inflammatory diseases
07/03/2003US20030125294 Selective toxin expression in angiogenic endothelial cells
07/03/2003US20030125290 Cancer treatment with a synthetic sequences
07/03/2003US20030125286 Transcriptional silencer protein NRF
07/03/2003US20030125285 Method of examining efficacy of therapy with nucleic acid
07/03/2003US20030125262 Methods and reagents for regulation of cellular responses in biological systems
07/03/2003US20030125260 Administering to the mammal a therapeutically acceptable amount of a tetra or pentapeptide compound to inhibit the angiogenesis
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125252 Administering to a vertebrate an effective osteogenesis stimulating amount of an RAR (retinoic acid receptor) antagonist to treat both metabolic or non-metabolic diseases; RAR antisense oligonucleotide
1 ... 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 ... 2211